Assignee
KINDEX PHARMACEUTICALS INC
US·4 granted patents·1 pending application·0 citations·filing 2013–2018
Top patents by PatentIndex Score
5 records- 0156US8829056B2Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methodsKINDEX PHARMACEUTICALS INC·Filed 2013·Granted Sep 9, 2014·0 cites·7 claims
- 0246US10343977B2Tetrahydro-isohumulone derivatives, methods of making and usingKINDEX PHARMACEUTICALS INC·Filed 2017·Granted Jul 9, 2019·0 cites·1 claims
- 0342US2020179308A1Use of isohumulones and derivatives thereof to treat polycystic ovary syndromeKINDEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0437US9828331B2Tetrahydro-isohumulone derivatives, methods of making and usingKINDEX PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·0 cites·1 claims
- 0533US9340479B2Methods of synthesizing alpha acids and substantially enantiomerically pure compositions thereofKINDEX PHARMACEUTICALS INC·Filed 2015·Granted May 17, 2016·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when KINDEX PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →